Tiger Group’s Remarketing Services Division is now accepting sealed bid offers for intellectual property, inventory and other assets of Biotech International Corporation, including its flagship DermaSilk brand, a leading line of anti-aging and skincare products. The sale is being conducted on behalf of First Niagara Bank NA, the secured creditor for Glastonbury, CT-based Biotech International.
Recognized as one of the Top-10 anti-aging products in the US, DermaSilk’s products are carried by such top retailers as CVS, Walgreens, Wal-Mart, Rite Aid, Sears and Kroger.
Assets being sold include popular product lines and trademarks for DermaSilk, formulas and customer lists. More than $1 million of finished goods will also be available for sale, along with thousands of units of packaging and displays. The assets are being offered for sale on a turnkey basis or in any combination. Sealed bids will be accepted through 5:00 p.m. EST, February 19.
DermaSilk targets the $2.2 billion U.S. anti-aging skincare market, one of the fastest growing sectors in the $96.5 billion global skincare market. Successful lines up for bid include DermaSilk 5 Minute Face Lift, 90 Second Eye Lift, Flawless, Ultimate Face Lift, DermaSilk Triple-Sculpting cream, DermaSilk 30 Second Neck Lift, and DermaSilk 1 Minute Collagen Lift. The popularly-priced products retail in the $19.95 to $39.95 range.
“Health and beauty companies, or other businesses with skincare and cosmetic lines will be interested in this unique opportunity for a brand that ranked sixth domestically in a category that includes such names as Oil of Olay, L’Oreal and Neutrogena,” said Andy Babcock, Tiger Group’s Director of Inventory Strategies. “Demand for DermaSilk continues to be robust.”
More info: http://auctions.tigergroupllc.com/cgi-bin/mndetails.cgi?tigergrp105. To arrange for a viewing of the inventory, contact Andy Babcock, email@example.com or Robert Indiviglio, firstname.lastname@example.org.